Atlas Trials

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

RecordFirmDate
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer (NCT07480356)Protara Therapeutics2026-05-29
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer (NCT06545955)Ferring Pharmaceuticals2024-10-01
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve (NCT04752722)enGene, Inc.2021-04-22

Track Non-muscle Invasive Bladder Cancer With Carcinoma in Situ automatically

Every clearance here is in the API, with alerts when new ones post.